Finnish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Acute Undifferentiated Fever in Ethiopia

Vain rekisteröityneet käyttäjät voivat kääntää artikkeleita
Kirjaudu sisään Rekisteröidy
Linkki tallennetaan leikepöydälle
TilaAktiivinen, ei rekrytoi
Sponsorit
Institute of Tropical Medicine, Belgium
Yhteistyökumppanit
University of Gondar

Avainsanat

Abstrakti

A cross-sectional study on acute undifferentiated fever and the utility of biomarkers in differentiating bacterial from viral infection among acute febrile patients in Gondar, northwest Ethiopia.

Kuvaus

General objective:

To assess the causes of acute undifferentiated febrile illness and evaluation of biomarkers for differentiation of bacterial and viral infections among outpatients at University of Gondar (UOG) Hospital, Northwest Ethiopia

Specific objectives

1. To determine the number of malaria cases, bacterial infections (by blood culture and polymearase chain reaction (PCR) for Rickettsia and Borrelia), and arboviral infections (DENV, YFV, CHIKV) among all acute febrile patients

2. To evaluate the diagnostic performance different assays (RDT, RT-(reverse transcriptase)PCR, ELISA) for the diagnosis of DENV

3. To evaluate the qualitative detection of C-reactive protein (CRP) and Myxovirus resistance protein (MxA) (by FebriDx RDT) and quantitative CRP detection for differentiating bacterial and viral infections

Study design, population, materials and methods: a cross-sectional cohort study on febrile patients presenting with acute fever at the emergency ward of the UOG hospital from June to August 2019. Clinical and epidemiological data will be recorded in a pseudo-anonymized and collected using an electronic data collection tool (KoBoToolbox). Blood will be collected for RDT testing, blood culture, PCR and serum for ELISA and RT-PCR.

Sample size: 200 acute febrile patients

Expected results and relevance: Evaluation of the causes of acute febrile illness and the role of biomarkers in differentiating viral and bacterial infections will increase the awareness of circulating pathogens and improve patient management. This evidence will contribute to a more rational use of laboratory diagnostic tests, antibiotics and antimalarial treatment.

Päivämäärät

Viimeksi vahvistettu: 01/31/2020
Ensimmäinen lähetys: 02/10/2020
Arvioitu ilmoittautuminen lähetetty: 02/10/2020
Ensimmäinen lähetetty: 02/12/2020
Viimeisin päivitys lähetetty: 02/13/2020
Viimeisin päivitys lähetetty: 02/17/2020
Todellinen opintojen alkamispäivä: 05/31/2019
Arvioitu ensisijainen valmistumispäivä: 08/30/2019
Arvioitu tutkimuksen valmistumispäivä: 12/29/2020

Ehto tai tauti

Acute Febrile Illness

Vaihe

-

Kelpoisuusehdot

Tutkimukseen soveltuvat iät 15 Years Vastaanottaja 15 Years
Sukupuolet, jotka ovat kelpoisia tutkimukseenAll
NäytteenottomenetelmäProbability Sample
Hyväksyy terveelliset vapaaehtoisetEi
Kriteeri

Inclusion Criteria:

- Patients presenting with acute fever (an axillary temperature of ≥37.5°C; symptom duration ≤7 days)

- ≥ 15 years old

- signed informed consent

Exclusion Criteria:

- pregnant woman & children (<15 y)

- febrile patient suspected of urinary tract infection or acute respiratory tract infection

- Individuals who had taken antimicrobial and antimalarial drug in the last 2 weeks

- Patients with acute injury or trauma or for which participation in the study implies an unacceptable health risk as determined by the physicians

Tulokset

Ensisijaiset tulosmittaukset

1. The differentiation of bacterial infections and viral infections among acute febrile patients with biomarkers [within 7 days after onset of fever]

CRP (bacterial biomarker) and MxA (viral biomarker) will be evaluated for differentiating confirmed bacterial and viral infections.

Toissijaiset tulosmittaukset

1. The number of malaria cases, bacterial infections, viral infections and unknown etiologies among acute febrile patients in Gondar [within 7 days after onset of fever]

Different diagnostic tools will be used for analysis of acute febrile patient samples to confirm malaria (by RDT), bacterial infection (by blood culture and PCR for Rickettsia and Borrelia) and for viral infections (by RT-PCR for DENV, CHIKV, YFV). Samples negative for all these tests are defined as unknown etiology.

2. The comparison of different assays for diagnosis of DENV [within 7 days after onset of fever]

Different diagnostic tests will be evaluated for the detection of acute DENV infection (NS1 RDT, RT-PCR, ELISA IgM) and past DENV infection (ELISA IgG) among acute febrile patients.

3. The comparison of the qualitative and qualitative detection of CRP for differentiating bacterial and viral infections [within 7 days after onset of fever]

Qualitative CRP levels will be measured by FebriDx test and quantitative CRP levels will be measured by QuikReadGo. The detection of > 20mg/L CRP will be used to evaluate the confirmed bacterial infections and to compare with antibiotic treatment.

Liity facebook-sivullemme

Täydellisin lääketieteellinen tietokanta tieteen tukemana

  • Toimii 55 kielellä
  • Yrttilääkkeet tieteen tukemana
  • Yrttien tunnistaminen kuvan perusteella
  • Interaktiivinen GPS-kartta - merkitse yrtit sijaintiin (tulossa pian)
  • Lue hakuusi liittyviä tieteellisiä julkaisuja
  • Hae lääkekasveja niiden vaikutusten perusteella
  • Järjestä kiinnostuksesi ja pysy ajan tasalla uutisista, kliinisistä tutkimuksista ja patenteista

Kirjoita oire tai sairaus ja lue yrtteistä, jotka saattavat auttaa, kirjoita yrtti ja näe taudit ja oireet, joita vastaan sitä käytetään.
* Kaikki tiedot perustuvat julkaistuun tieteelliseen tutkimukseen

Google Play badgeApp Store badge